ProjectUpdated on 4 August 2025
Lithium Ion Batteries Recycling
About
Achelous Pure Metal (APM) offers an innovative project opportunity in modular lithium-ion battery recycling microfactories—each capable of processing 500kg of black mass per day, with unlimited scaling potential through multiple units. Our localized solution eliminates transport costs, cuts CO₂ emissions, and recovers high-purity metals (Lithium, Nickel, Cobalt) for direct reuse in battery supply chains.
Local recycling, Global Impact.
Project Location
- Malaysia
 
Project Format
- Private Project
 
ESG (Environmental, Social, and Governance)
- Yes
 
Project Stage
- Construction
 
Main Project Sector
- Technology
 
Energy and Natural Resources
- Waste To Energy
 
Public Utilities
- Waste Treatment
 
Technology
- Environmental Technology
 
Urban Development
- Smart City Development
 
Total Project Value
- 1,000,001 to 2,500,000 USD
 
Investment Capital Required
- 1,000,001 to 2,500,000 USD
 
Interested Format of Cooperation
- Minority Shareholdings
 - Open for Negotiation
 
Preferred Financing Model
- Equity
 - Open for negotiation
 
Previous Funding Stage
- Seed & Pre-Series
 
Main Service(s) Required
- Financial Services
 
Financial Services
- Private Equity & Venture Capital
 
Organisation
Achelous Pure Metal Company Limited
Hong Kong, China
Similar opportunities
Project
Food Processors (https://foodprocessors.com.fj/products/)
- Yes
 - None
 - Operations
 - Joint Venture
 - Private Project
 - Open for Negotiation
 - Open for negotiation
 - Professional Services
 - 1,000,001 to 2,500,000 USD
 - 1,000,001 to 2,500,000 USD
 - Agriculture, Food and Rural Development
 
Jane Ma, CFA
Head of Investments at Pacific Trade Invest China 太平洋岛国贸易与投资专员署
Nadi, Fiji
Project
- Yes
 - None
 - Equity
 - Technology
 - Manufacturing
 - Private Project
 - 500,000 USD or Below
 - Open for Negotiation
 - Open for negotiation
 - Minority Shareholdings
 - 1,000,001 to 2,500,000 USD
 - Feasibility Study Completed
 - Information Technology Services
 
XIANGQIAN SHI
CEO at Hopebotics
HONG KONG, China (Hong Kong)
Project
Single Cell Drug Screening AI Platform
- Yes
 - None
 - Equity
 - Bio-Tech
 - Technology
 - Private Project
 - R&D Cooperation
 - Open for negotiation
 - Professional Services
 - Minority Shareholdings
 - 2,500,001 to 5,000,000 USD
 - 1,000,001 to 2,500,000 USD
 - Feasibility Study Completed
 - Public–private partnership / Concession
 
Marco Suen
Founder & CEO at Provectus Therapeutics Limited
Hong Kong, China (Hong Kong)